Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1198 |
Phytochemical name or plant extracts |
23,24-Dihydrocucurbitacin B |
PMID |
17681423 |
Literature evidence |
In this study, DHCB, isolated from roots of Trichosanthes kirilowli which is a traditional Chinese herb medicine used as treatments for cancer and other diseases, has been found to inhibit the proliferation of human cancer cell lines Bcap37, HeLa, SW620, SMMC-7721, K562 and MCF-7 in a dose- and time-dependent manner, and induce apoptosis in human breast cancer cell line Bcap37 at low concentration. |
IUPAC name |
[(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate |
Phytochemicals’ class or type of plant extracts |
Alpha-hydroxy ketone |
Source of phytochemicals or plant Extracts |
Trichosanthes kirilowli |
|
Geographical availability |
Cambodia, China North-Central, China Southeast, Inner Mongolia, Japan, Korea, Laos, Nansei-shoto, Vietnam |
Plant parts |
Root |
Other cancers |
Breast cancer |
Target gene or protein |
NA |
Gene or Protein evidence |
NA |
Target pathways |
NA |
IC50 |
NA |
Potency |
Flow cytometric analysis revealed that at the lower dose of 1.8 and 3.6muM, DHCB-induced cancer cell lines death via an apoptotic process rather than necrotic one, whereas, the higher dose of 8.9, 17.9 and 35.7muM induced cell death via the necrotic process. |
Cell line/ mice model |
Bcap37, HeLa, SW620, SMMC-7721, K562, MCF-7 |
Additional information |
Cell-cycle analysis demonstrated DHCB induction of G(2)/M phase cell-cycle arrest and apoptosis.
The overall results suggest that DHCB might have the therapeutic value against human cancer cell lines, especially the breast cancer cell lines. |
PubChem ID |
267250 |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:294222-1 |
Safety |
NA |